About Us

Tyler is an accomplished senior leader whose primary focus is accelerating global growth strategy, maintaining operational excellence, guiding corporate investments, and building corporate portfolios. Since joining Science 37 in 2021, he has played an instrumental role in developing and executing our corporate strategy, which includes organizational design optimization and leading M&A transactions.

Previously, Tyler was head of various business units at IQVIA. During his tenure at the health information technology and clinical research company, he led major investments in global commercial strategy, operational transformation, financial optimization, product development, and other clinical programs that resulted in rapid, sustainable growth.

Tyler completed his MBA in Strategy and Leadership at the UNC Kenan-Flagler Business School and BS in Economics at NC State University. He is an active volunteer at charitable organizations that benefit unhoused and underprivileged families in the Triangle area.

Jonathan Cotliar has been Chief Medical Officer of Science 37 since November 2016. Prior to assuming this role, from November 2016 to May 2019, Jonathan served as Vice President of Medical Affairs of Science 37, where he contributed as an investigator on a number of virtual clinical trials in addition to his work in support of business development and regulatory strategy. He currently serves as Director of Inpatient Dermatology at Harbor-UCLA Medical Center, with previous full-time faculty appointments at the David Geffen School of Medicine at UCLA, Northwestern University Feinberg School of Medicine, and City of Hope National Medical Center, where he was Chief of the Division of Dermatology. Jonathan earned his B.A. from Trinity College, MD from the University of Kentucky College of Medicine, and completed his training in dermatology and internal medicine at the David Geffen School of Medicine at UCLA. While at UCLA, he completed an NIH-sponsored K30 Fellowship in translational investigation. Jonathan is also board-certified in both internal medicine and dermatology.

Irena Lambridis joined Science 37 in April 2023 as VP, Head of Quality Assurance & Compliance. Irena has spent the greater part of the past 20 years leading global, quality-focused groups within Chiltern/Covance and Novella Clinical/IQVIA Biotech and most recently as Head of Quality Assurance & Compliance and Learning & Development at KCR. With extensive expertise in ISO 9001-2015, GCP, CSV, GLP and GMP, Irena is positioned to lead Science 37 with a focus on quality across the organization.